8-K: Milestone Scientific Secures Shareholder Lock-Up

Milestone Scientific Inc. entered an Amended and Restated Memorandum of Understanding with Innovest S.p.A. for a 12-month lock-up on 11.31% of its shares held by BP4 S.r.l., contingent on a $2.5 million offering.

Summary

• Milestone Scientific Inc. (the Company) entered into an Amended and Restated Memorandum of Understanding (MOU) with Innovest S.p.A. on January 15, 2026.
• Innovest S.p.A. holds consent/blockage rights for BP4 S.r.l., which owns 11.31% of the Company's outstanding common stock.
• BP4 agreed to a 12-month lock-up on its shares, preventing sales or transfers, subject to certain conditions.
• The lock-up period commences following the consummation of a $2.5 million offering by the Company.
• Exceptions to the lock-up allow for phased distribution of shares if the Company's stock closes above specific price thresholds for 10 consecutive trading days: 33.33% at $0.50, an additional 33.3% at $0.70 (cumulative 66.66%), and a final 33.3% at $0.90 (cumulative 100%).
• BP4's shareholders approved the MOU on January 15, 2026.

Sentiment

Score: 6

Explanation: The agreement provides a temporary lock-up on a significant block of shares, which is generally positive for stability. However, the conditions for early release and the contingency on a future offering introduce elements of uncertainty and potential future selling pressure.

Positives

• A significant shareholder (BP4, holding 11.31%) has agreed to a 12-month lock-up on its shares, reducing immediate selling pressure.
• The lock-up is contingent on a $2.5 million offering, suggesting a planned capital infusion for the company.
• The phased release of shares is tied to increasing stock price performance ($0.50, $0.70, $0.90), potentially incentivizing share price growth.

Negatives

• The lock-up is contingent on a future $2.5 million offering, which has not yet been consummated.
• The conditions for early release of shares (stock closing above $0.50, $0.70, $0.90 for 10 consecutive days) could create future selling pressure if these thresholds are met.
• BP4's 11.31% stake represents a substantial block of shares that could eventually enter the market.

Risks

• Future Selling Pressure: If Milestone Scientific's stock price reaches $0.50, $0.70, or $0.90 for 10 consecutive trading days, BP4 may distribute up to 100% of its 11.31% stake, potentially increasing the supply of shares and exerting downward pressure on the stock price.
• Offering Contingency: The lock-up is contingent on the consummation of a $2.5 million offering, and failure to complete this offering could negate the lock-up agreement.
• Shareholder Influence: Innovest S.p.A. holds "consent/blockage rights" with respect to BP4, indicating a level of influence over a significant shareholder.

Future Outlook

The lock-up agreement outlines a future scenario where a significant shareholder's ability to sell shares is tied to the company's stock price performance and the successful completion of a $2.5 million offering. This suggests a strategic effort to stabilize the share base while potentially raising capital. The phased release conditions provide clear price targets that, if met, will allow for the distribution of shares.

Industry Context

This filing primarily concerns a specific corporate governance and shareholder relations matter rather than broader industry trends. Shareholder lock-up agreements are common in various industries, particularly after capital raises or significant ownership changes, to manage market supply and investor confidence.

Corporate Governance

Related Party Transactions

• The agreement is with Innovest S.p.A., which holds consent/blockage rights for BP4 S.r.l., a company that owns 11.31% of Milestone Scientific Inc.'s outstanding common stock. This constitutes a material agreement with a significant shareholder.

Stakeholder Impact

• Shareholders: The lock-up could reduce immediate selling pressure from a large shareholder, potentially stabilizing the stock price. However, the future release conditions could create an overhang. The planned $2.5 million offering, if it occurs, would dilute existing shareholders but provide capital.
• Company Management: The agreement provides a framework for managing a significant shareholder's stake and aligns with a potential capital raise strategy.

Next Steps

• Consummation of the $2.5 million offering by Milestone Scientific Inc.
• Monitoring the Company's stock price performance against the $0.50, $0.70, and $0.90 thresholds for potential share distributions by BP4.

Key Dates

Recommendation

The lock-up agreement provides a degree of stability by preventing a large shareholder from immediately selling a significant block of shares. This is a positive for investor confidence. However, the future potential for these shares to be distributed if certain price thresholds are met, combined with the contingency on a future capital raise, introduces uncertainty. Investors should hold to observe the outcome of the $2.5 million offering and the company's ability to sustain stock prices above the specified thresholds before making further investment decisions.

Keywords

Milestone Scientific, MLSS, SEC filing, 8-K, shareholder agreement, lock-up agreement, Innovest S.p.A., BP4 S.r.l., common stock, capital raise, stock price thresholds, corporate governance